TherapeuticsMD reported $20K in Interest Expense on Debt for its fiscal quarter ending in September of 2023.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Cipla INR 140.3M 8.5M Dec/2025
Compugen USD 954K 116K Sep/2025
CSL USD 104M 136M Jun/2025
Grifols EUR 156.07M 31.46M Sep/2025
Pfizer USD 711M 59M Dec/2025
TherapeuticsMD USD 20K 25K Sep/2023